
    
      The study will be divided into two parts: a "dose-escalation part" to evaluate safety profile
      and to explore the Maximum tolerated dose (MTD) and an "expansion part" to evaluate further
      the safety and tumor response profile of BAY1862864 Injection at the selected dose.
    
  